Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Waldenström Macroglobulinemia (WM)”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Not applicableEnrolling By InvitationNCT07173790
What this trial is testing

Watch and Wait or Worry and Wait in Indolent Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)Marginal Zone Lymphoma(MZL)Follicular Lymphoma, Grade 1+3 more
Seoul National University Hospital 250
Early research (Phase 1)Not Yet RecruitingNCT07169565
What this trial is testing

Ibrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia (WM)
Institute of Hematology & Blood Diseases Hospital, China 21
Testing effectiveness (Phase 2)Study completedNCT00003416
What this trial is testing

S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
SWOG Cancer Research Network 9
Testing effectiveness (Phase 2)Looking for participantsNCT07249905
What this trial is testing

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Who this might be right for
LymphomaWaldenström Macroglobulinemia (WM)DLBCL - Diffuse Large B Cell Lymphoma+5 more
ModeX Therapeutics, An OPKO Health Company 180
Early research (Phase 1)Active Not RecruitingNCT05753501
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Who this might be right for
Hematologic Cancer
AbbVie 135
Testing effectiveness (Phase 2)Study completedNCT02677324
What this trial is testing

Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Dana-Farber Cancer Institute 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07259122
What this trial is testing

A Phase II Clinical Study of Zanubrutinib Combined With Four Cycles of CD20 Monoclonal Antibody and Reduced-Dose Bendamustine in the Treatment of Untreated Waldenström Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia (WM)
Institute of Hematology & Blood Diseases Hospital, China 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT04273139
What this trial is testing

Ibrutinib + Venetoclax in Untreated WM

Who this might be right for
Waldenstrom MacroglobulinemiaMYD88 Gene Mutation
Dana-Farber Cancer Institute 45
Early research (Phase 1)Ended earlyNCT04115059
What this trial is testing

Dasatinib In Waldenström Macroglobulinemia

Who this might be right for
Waldenstrom MacroglobulinemiaDASATINIB
Jorge J. Castillo, MD 3
Early research (Phase 1)Not Yet RecruitingNCT07424833
What this trial is testing

APG-3288 in Relapsed/Refractory Blood Cancers

Who this might be right for
Relapsed/Refractory Hematological MalignanciesRelapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLLRelapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including Richter Transformation)+4 more
Ascentage Pharma Group Inc.
Very early researchStudy completedNCT03771157
What this trial is testing

Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Waldenstrom Macroglobulinemia (WM)
University of Rochester 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT02180724
What this trial is testing

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia (WM)
Acerta Pharma BV 107
Early research (Phase 1)Looking for participantsNCT05780034
What this trial is testing

AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell Malignancies
Accutar Biotechnology Inc 60
Not applicableStudy completedNCT00919139
What this trial is testing

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

Who this might be right for
Multiple MyelomaSmoldering MyelomaWaldenstrom's Macroglobulinemia+2 more
SWOG Cancer Research Network 190
Not applicableNo Longer AvailableNCT04052854
What this trial is testing

A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies

Who this might be right for
Waldenström Macroglobulinemia
BeiGene
Testing effectiveness (Phase 2)Looking for participantsNCT05190705
What this trial is testing

Loncastuximab Tesirine in WM

Who this might be right for
Waldenstrom Macroglobulinemia
Shayna Sarosiek, MD 36
Testing effectiveness (Phase 2)Study completedNCT00005609
What this trial is testing

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT06561347
What this trial is testing

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

Who this might be right for
Waldenstrom Macroglobulinemia
Massachusetts General Hospital 55
Testing effectiveness (Phase 2)Looking for participantsNCT07387471
What this trial is testing

Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

Who this might be right for
Waldenstrom MacroglobulinemiaLymphoplasmacytic Lymphoma
AbbVie 14
Post-approval studies (Phase 4)Study completedNCT02844309
What this trial is testing

The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM

Who this might be right for
Waldenström Macroglobulinemia
Institute of Hematology & Blood Diseases Hospital, China 44
180